How is Revlimid used in multiple myeloma?
Revlimid is a commonly used drug in all stages of multiple myeloma. Although it can be used alone, it is usually used in combination with another anti-myeloma drug, Dexamethasone: A steroid used in the treatment of multiple myeloma, often in combination with another anti-myeloma drug. Decadron® is one brand of dexamethasone.’)”>dexamethasone (dex). This combination is called Revlimid-dex. The combination of Revlimid plus dexamethasone has been shown to be more effective than either drug taken alone. Revlimid-dex is approved by the FDA for the treatment of multiple myeloma patients who have received at least one prior therapy. It is also commonly used for newly diagnosed or untreated patients. Revlimid is now being studied for use as Maintenance therapy: Treatment that is given to patients in remission over a long period of time, in order to reduce the risk of relapse.’)”>maintenance therapy following High-dose chemotherapy: Administration of very high doses of chemotherapy that may be
